PHARMANOU: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMANOU
Largest movements
- Cash +€66,019
up €66,019 (+158%), from €41,845 to €107,865
mainly Net result for the year (+€60,360) and Tax, wage and social debts (+€9,937)
- Tangible fixed assets +€2,151
new in 2025: €2,151
- Receivables within one year +€1,370
up €1,370 (+188%), from €730 to €2,100
of which Trade receivables: +€1,536
- Profit (loss) carried forward +€59,527
up €59,527 (+221%), from €26,966 to €86,492
- Tax, wage and social debts +€9,937
up €9,937 (+83.0%), from €11,974 to €21,911
of which Taxes: +€9,937
- Gross operating margin +€42,526
up €42,526 (+121%), from €35,265 to €77,791
- Taxes +€8,969
up €8,969 (+123%), from €7,320 to €16,289
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €42,576 | €112,116 | +€69,540 | +163% |
| Fixed assets | 21/28 | - | €2,151 | +€2,151 | |
| Tangible fixed assets | 22/27 | - | €2,151 | +€2,151 | |
| Furniture and vehicles | 24 | - | €2,151 | +€2,151 | |
| Current assets | 29/58 | €42,576 | €109,965 | +€67,389 | +158% |
| Amounts receivable within one year | 40/41 | €730 | €2,100 | +€1,370 | +188% |
| Trade receivables | 40 | €564 | €2,100 | +€1,536 | +273% |
| Other amounts receivable | 41 | €167 | - | -€167 | |
| Cash at bank and in hand | 54/58 | €41,845 | €107,865 | +€66,019 | +158% |
| Total equity and liabilities | 10/49 | €42,576 | €112,116 | +€69,540 | +163% |
| Equity | 10/15 | €28,966 | €88,492 | +€59,527 | +206% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €26,966 | €86,492 | +€59,527 | +221% |
| Amounts payable | 17/49 | €13,610 | €23,624 | +€10,014 | +73.6% |
| Amounts payable within one year | 42/48 | €13,110 | €23,124 | +€10,014 | +76.4% |
| Trade debts | 44 | €535 | €526 | -€9 | -1.6% |
| Suppliers | 440/4 | €535 | €526 | -€9 | -1.6% |
| Taxes, remuneration and social security | 45 | €11,974 | €21,911 | +€9,937 | +83.0% |
| Taxes | 450/3 | €10,374 | €20,311 | +€9,937 | +95.8% |
| Remuneration and social security | 454/9 | €1,600 | €1,600 | = | 0.0% |
| Other amounts payable | 47/48 | €601 | €687 | +€85 | +14.2% |
| Accrued charges and deferred income | 492/3 | €500 | €500 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €274 | +€274 | |
| Other operating charges | 640/8 | €106 | €200 | +€95 | +89.6% |
| Gross operating margin | 9900 | €35,265 | €77,791 | +€42,526 | +121% |
| Operating profit (loss) | 9901 | €35,159 | €77,317 | +€42,158 | +120% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €14 | €668 | +€654 | +4,533% |
| Recurring financial charges | 65 | €14 | €668 | +€654 | +4,533% |
| Profit (loss) for the period before taxes | 9903 | €35,145 | €76,649 | +€41,504 | +118% |
| Income taxes | 67/77 | €7,320 | €16,289 | +€8,969 | +123% |
| Profit (loss) for the period | 9904 | €27,825 | €60,360 | +€32,535 | +117% |
| Profit (loss) for the period to be appropriated | 9905 | €27,825 | €60,360 | +€32,535 | +117% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.